Food and Drug Administration to Host Stem Cell Webinar March 8

Every other month, the Food and Drug Administration (FDA) hosts the FDA Grand Rounds webinar series highlighting the latest research its scientists are conducting. An FDA scientist attends each webcast to discuss this work in depth, as well as the role of science in the FDA’s legislative and regulatory activities.

As biomedical advancements continue to be made in leaps and bounds the FDA will be examining stem cells, a lynchpin to many bioengineering activities, in the next webinar. The webinar, titled “Are Stem Cells Ready for Prime Time? A Look at FDA Research Advances in Regenerative Medicine” features Steven Bauer, PhD, Chief of Cellular and Tissue Therapy in the FDA’s Center for Biologics Evaluation and Research, as the main presenter. The webinar will discuss the FDA scientist’s research into identifying the characteristics of cell therapy products that indicate a higher likelihood of success in human cell-based therapies.

To learn more about the webinar and register, click here: https://www.fda.gov/ScienceResearch/AboutScienceResearchatFDA/ucm486711.htm